Cipla Q4 net profit slumps 55% YoY to Rs 555 crore, full-year PAT down 26%

Pharma major Cipla announced a significant 55% drop in its net profit for the March quarter. Total income also saw a 3% decrease. For the full financial year, revenue grew slightly by 2%, but profit after tax declined by 26%. The company's MD highlighted strong performance in key therapy areas and sustained growth in its generics and consumer health businesses.